| Timothy Douglas Jenkins, MD | |
|
2410 Susannah Street, Johnson City, TN 37601 | |
| (423) 282-9011 | |
| (423) 282-0035 |
| Full Name | Timothy Douglas Jenkins |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 21 Years |
| Location | 2410 Susannah Street, Johnson City, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043421779 | NPI | - | NPPES |
| 1505390 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD0000043343 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellmont Holston Valley Medical Center | Kingsport, TN | Hospital |
| Johnson City Medical Center | Johnson city, TN | Hospital |
| Lonesome Pine Hospital | Big stone gap, VA | Hospital |
| Franklin Woods Community Hospital | Johnson city, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Champion Physical Therapy Llc Halls | 1355416306 | 241 |
| Watauga Orthopaedics Plc | 1456246479 | 62 |
News Archive
A protein known as arginine methyltransferase 1 (PRMT1) may be a potential therapeutic target for pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer, and one of the most deadliest with a less than 10 percent, five-year survival rate.
Myriad Pharmaceuticals, Inc. today announced the presentation of clinical data from two separate Phase 2a combination drug studies of AzixaTM (MPC-6827, verubulin) at the American Society of Clinical Oncology 2010 Annual Meeting in Chicago, IL. Results from studies in both recurrent glioblastoma multiforme and stage 4 metastatic melanoma demonstrated that Azixa, in combination with standard treatments, resulted in durable responses with no added toxicity compared with chemotherapy alone.
To help unravel the mysteries of human cognitive development and reach new the frontiers in robotics, University of Miami (UM) developmental psychologists and computer scientists from the University of California in San Diego (UC San Diego) are studying infant-mother interactions and working to implement their findings in a baby robot capable of learning social skills.
According to the latest research the use of radioactive iodine to treat thyroid cancer increased 40 percent from 1990 to 2008 even though the risks may outweigh the benefits for some patients, particularly those with early-stage tumors.
› Verified 3 days ago
| Entity Name | Watauga Orthopaedics Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245251404 PECOS PAC ID: 1456246479 Enrollment ID: O20040218000903 |
News Archive
A protein known as arginine methyltransferase 1 (PRMT1) may be a potential therapeutic target for pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer, and one of the most deadliest with a less than 10 percent, five-year survival rate.
Myriad Pharmaceuticals, Inc. today announced the presentation of clinical data from two separate Phase 2a combination drug studies of AzixaTM (MPC-6827, verubulin) at the American Society of Clinical Oncology 2010 Annual Meeting in Chicago, IL. Results from studies in both recurrent glioblastoma multiforme and stage 4 metastatic melanoma demonstrated that Azixa, in combination with standard treatments, resulted in durable responses with no added toxicity compared with chemotherapy alone.
To help unravel the mysteries of human cognitive development and reach new the frontiers in robotics, University of Miami (UM) developmental psychologists and computer scientists from the University of California in San Diego (UC San Diego) are studying infant-mother interactions and working to implement their findings in a baby robot capable of learning social skills.
According to the latest research the use of radioactive iodine to treat thyroid cancer increased 40 percent from 1990 to 2008 even though the risks may outweigh the benefits for some patients, particularly those with early-stage tumors.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Timothy Douglas Jenkins, MD 2410 Susannah St, Johnson City, TN 37601-1765 Ph: (423) 282-9011 | Timothy Douglas Jenkins, MD 2410 Susannah Street, Johnson City, TN 37601 Ph: (423) 282-9011 |
News Archive
A protein known as arginine methyltransferase 1 (PRMT1) may be a potential therapeutic target for pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer, and one of the most deadliest with a less than 10 percent, five-year survival rate.
Myriad Pharmaceuticals, Inc. today announced the presentation of clinical data from two separate Phase 2a combination drug studies of AzixaTM (MPC-6827, verubulin) at the American Society of Clinical Oncology 2010 Annual Meeting in Chicago, IL. Results from studies in both recurrent glioblastoma multiforme and stage 4 metastatic melanoma demonstrated that Azixa, in combination with standard treatments, resulted in durable responses with no added toxicity compared with chemotherapy alone.
To help unravel the mysteries of human cognitive development and reach new the frontiers in robotics, University of Miami (UM) developmental psychologists and computer scientists from the University of California in San Diego (UC San Diego) are studying infant-mother interactions and working to implement their findings in a baby robot capable of learning social skills.
According to the latest research the use of radioactive iodine to treat thyroid cancer increased 40 percent from 1990 to 2008 even though the risks may outweigh the benefits for some patients, particularly those with early-stage tumors.
› Verified 3 days ago
Richard W Duncan, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2410 Susannah St, Johnson City, TN 37601 Phone: 423-282-9011 Fax: 423-282-0035 | |
Dr. David R Hardin, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 111 Pine Ct, Johnson City, TN 37601 Phone: 423-434-0014 Fax: 423-434-0014 | |
Dr. Jeffrey Alan Marchessault, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 410 N State Of Franklin Rd Ste 140, Johnson City, TN 37604 Phone: 423-431-2460 Fax: 423-431-2456 | |
Robert M Harris, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 410 N State Of Franklin Rd Ste 140, Johnson City, TN 37604 Phone: 423-431-2460 | |
Dr. Henry J. Williams, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3 Professional Park Dr, Suite 21, Johnson City, TN 37604 Phone: 423-979-3333 Fax: 423-926-6713 | |
Dr. Thomas L Huddleston, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3 Professional Park Dr, Suite 21, Johnson City, TN 37604 Phone: 423-434-6300 Fax: 423-434-6312 |